Crinetics to Present New Long-Term Data Demonstrating Durable Control of Once-Daily, Oral PALSONIFY\u2122 (Paltusotine) in Acrom

• click to rate

  Posted by Two Blokes Jul 14 - Filed in Stock - 2 views
  
  Data show that PALSONIFY was well tolerated and IGF-1 levels remained stably controlled during long-term open label extensions of PATHFNDR-1 and PATHFNDR-2 studies